Patricia L. Allen's most recent trade in Zenas Biopharma Inc. was a trade of 18,500 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 10, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Zenas Biopharma Inc. | Patricia L. Allen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2025 | 18,500 | 18,500 | - | - | Stock Option (Right to Buy) | |
| Deciphera Pharmaceuticals Inc | Patricia L. Allen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jan 2024 | 4,727 | 4,727 | - | - | Stock Option (Right to Buy) | |
| Deciphera Pharmaceuticals Inc | Patricia L. Allen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jun 2023 | 30,000 | 30,000 | - | - | Stock Option (Right to Buy) | |
| Deciphera Pharmaceuticals Inc | Patricia L. Allen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2023 | 3,269 | 3,269 | - | - | Stock Option (Right to Buy) | |
| Deciphera Pharmaceuticals Inc | Patricia L. Allen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jun 2022 | 18,500 | 18,500 | - | - | Stock Option (Right to Buy) | |
| Deciphera Pharmaceuticals Inc | Patricia L. Allen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jan 2022 | 9,570 | 9,570 | - | - | Stock Option (Right to Buy) | |
| Deciphera Pharmaceuticals Inc | Patricia L. Allen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jun 2021 | 12,000 | 12,000 | - | - | Stock Option (Right to Buy) |